docetaxel anhydrous has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhowaish, A; Borradori, L; Lebeau, S; Masouyé, I; Sallam, MA; També, S; Tschanz, C | 1 |
| Dillon, PM; Greer, KE; Marchetti, MA; Noland, MM | 1 |
| Parsons, LM; Trotter, MJ; Tsang, RY; Wong, NY | 1 |
| Antiga, E; Bonciani, D; Bonciolini, V; Caproni, M; Maio, E; Verdelli, A; Volpi, W | 1 |
| Belum, VR; Dalenc, F; Deslandres, M; Eche, A; Gladieff, L; Lacouture, ME; Lebœuf, NR; Montastruc, M; Roche, H; Sibaud, V; Vigarios, E | 1 |
| Bagot, M; Cosnes, A; Duong, TA; Gantzer, A; Ortonne, N; Regnier, S; Wolkenstein, P | 1 |
| Chen, M; Crowson, AN; Luca, MB; Magro, CM; Woofter, M | 1 |
2 review(s) available for docetaxel anhydrous and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Dermatological adverse events with taxane chemotherapy.
Topics: Alopecia; Antineoplastic Agents; Docetaxel; Drug Eruptions; Edema; Humans; Lupus Erythematosus, Cutaneous; Nail Diseases; Paclitaxel; Pigmentation Disorders; Radiodermatitis; Taxoids | 2016 |
[Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
Topics: Adenocarcinoma; Aged; Antibodies, Antinuclear; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Bevacizumab; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Mastectomy; Middle Aged; Paclitaxel; Paraneoplastic Syndromes; Ribonucleoproteins; Salvage Therapy; Tamoxifen; Taxoids; Trastuzumab | 2011 |
5 other study(ies) available for docetaxel anhydrous and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Docetaxel-induced relapse of subacute cutaneous lupus erythematosus and chilblain lupus.
Topics: Antineoplastic Agents; Chilblains; Diagnosis, Differential; Docetaxel; Female; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Secondary Prevention; Taxoids | 2013 |
Taxane associated subacute cutaneous lupus erythematosus.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Disease Progression; Docetaxel; Female; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Taxoids | 2013 |
Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report.
Topics: Antibodies, Antinuclear; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Docetaxel; Drug Eruptions; Female; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Neoplasm Staging; Severity of Illness Index; Sjogren's Syndrome; Taxoids; Treatment Outcome | 2014 |
Docetaxel-induced-like subacute cutaneous lupus erythematosus.
Topics: Antineoplastic Agents; Docetaxel; Hand Dermatoses; Humans; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Taxoids; Torso | 2016 |
Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases.
Topics: Aged; Antineoplastic Agents, Phytogenic; Biomarkers; Complement Membrane Attack Complex; Dermatitis; Docetaxel; Female; Humans; Immunoglobulin G; Immunohistochemistry; Keratinocytes; Lupus Erythematosus, Cutaneous; Middle Aged; Mucins; Recovery of Function; Remission Induction; Skin; Taxoids | 2004 |